Search Results - "Perk, Lars R"
-
1
Immuno‐PET: A Navigator in Monoclonal Antibody Development and Applications
Published in The oncologist (Dayton, Ohio) (01-12-2007)“…Learning Objectives After completing this course, the reader will be able to: Discuss the technical advances that have led to recent rapid developments in…”
Get full text
Journal Article -
2
Optimised GMP-compliant production of [18F]DPA-714 on the Trasis AllinOne module
Published in EJNMMI radiopharmacy and chemistry (26-05-2021)“…Background The translocator protein 18 kDa is recognised as an important biomarker for neuroinflammation due to its soaring expression in microglia. This…”
Get full text
Journal Article -
3
11C-labeled and 18F-labeled PET ligands for subtype-specific imaging of histamine receptors in the brain
Published in Journal of labelled compounds & radiopharmaceuticals (01-03-2013)“…The signaling molecule histamine plays a key role in the mediation of immune reactions, in gastric secretion, and in the sensory system. In addition, it has an…”
Get full text
Journal Article -
4
Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p -isothiocyanatobenzyl-desferrioxamine
Published in Nature protocols (01-04-2010)“…The positron emitter zirconium-89 ( 89 Zr) has very attractive properties for positron emission tomography (PET) imaging of intact monoclonal antibodies (mAbs)…”
Get full text
Journal Article -
5
p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging
Published in European journal of nuclear medicine and molecular imaging (01-02-2010)“…Purpose Immuno-PET is an emerging imaging tool for the selection of high potential antibodies (mAbs) for imaging and therapy. The positron emitter zirconium-89…”
Get full text
Journal Article -
6
In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft
Published in The Journal of nuclear medicine (1978) (01-08-2007)“…Vascular endothelial growth factor (VEGF), released by tumor cells, is an important growth factor in tumor angiogenesis. The humanized monoclonal antibody…”
Get full text
Journal Article -
7
Synthesis and initial preclinical evaluation of the P2X7 receptor antagonist [11C]A-740003 as a novel tracer of neuroinflammation
Published in Journal of labelled compounds & radiopharmaceuticals (30-06-2014)“…Neuroinflammation, in particular activation of microglia, is thought to play an important role in the progression of neurodegenerative diseases. In activated…”
Get full text
Journal Article -
8
(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab
Published in The Journal of nuclear medicine (1978) (01-11-2005)“…Immuno-PET as a scouting procedure before radioimmunotherapy (RIT) aims at confirming tumor targeting and accurately estimating radiation dose delivery to both…”
Get full text
Journal Article -
9
(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy
Published in European journal of nuclear medicine and molecular imaging (01-08-2009)“…The human monoclonal antibody (MAb) fragment L19-SIP is directed against extra domain B (ED-B) of fibronectin, a marker of tumour angiogenesis. A clinical…”
Get full text
Journal Article -
10
Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography
Published in European journal of nuclear medicine and molecular imaging (01-11-2006)“…To evaluate whether (89)Zr can be used as a PET surrogate label for quantification of (90)Y-ibritumomab tiuxetan ((90)Y-Zevalin) biodistribution and dosimetry…”
Get full text
Journal Article -
11
(11) C-labeled and (18) F-labeled PET ligands for subtype-specific imaging of histamine receptors in the brain
Published in Journal of labelled compounds & radiopharmaceuticals (01-03-2013)“…The signaling molecule histamine plays a key role in the mediation of immune reactions, in gastric secretion, and in the sensory system. In addition, it has an…”
Get full text
Journal Article -
12
Technical Note: Building a combined cyclotron and MRI facility: Implications for interference
Published in Medical physics (Lancaster) (01-01-2013)“…Purpose: With the introduction of hybrid PET/MRI systems, it has become more likely that the cyclotron and MRI systems will be located close to each other…”
Get full text
Journal Article -
13
Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET
Published in European journal of nuclear medicine and molecular imaging (01-04-2011)“…Purpose The ∼15 kDa variable domains of camelid heavy-chain-only antibodies (called Nanobodies®) have the flexibility to be formatted as monovalent,…”
Get full text
Journal Article -
14
Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
Published in The Journal of nuclear medicine (1978) (01-06-2009)“…The anti-human epidermal growth factor receptor 2 (HER2/neu) antibody trastuzumab is administered to patients with HER2/neu-overexpressing breast cancer…”
Get full text
Journal Article -
15
124I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of 131I-L19-SIP radioimmunotherapy
Published in European journal of nuclear medicine and molecular imaging (01-08-2009)“…Purpose The human monoclonal antibody (MAb) fragment L19-SIP is directed against extra domain B (ED-B) of fibronectin, a marker of tumour angiogenesis. A…”
Get full text
Journal Article -
16
Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30
Published in European journal of nuclear medicine and molecular imaging (01-10-2008)“…Purpose Targeting the c-Met receptor with monoclonal antibodies (MAbs) is an appealing approach for cancer diagnosis and treatment because this receptor plays…”
Get full text
Journal Article -
17
Radioimmunotherapy for indolent B-cell non-Hodgkin lymphoma in relapsed, refractory and transformed disease
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01-01-2006)“…Radioimmunotherapy (RIT) is a new treatment modality that combines the benefits of radiotherapy and immunotherapy. In RIT, a radionuclide is coupled to a…”
Get full text
Journal Article -
18
Abstract 5275: Conjugation and radiolabeling of monoclonal antibodies and other proteins with 89Zr or 68Ga for PET imaging using p-isothiocyanatobenzyl-desferrioxamine
Published in Cancer research (Chicago, Ill.) (15-04-2011)“…Presently, hundreds of intact monoclonal antibodies (mAbs) and mAb fragments are under clinical development because of their excellent potential treatment of…”
Get full text
Journal Article -
19
Synthesis and initial preclinical evaluation of the P2X 7 receptor antagonist [ 11 C]A‐740003 as a novel tracer of neuroinflammation
Published in Journal of labelled compounds & radiopharmaceuticals (30-06-2014)“…Neuroinflammation, in particular activation of microglia, is thought to play an important role in the progression of neurodegenerative diseases. In activated…”
Get full text
Journal Article -
20
Facile labelling of an anti-epidermal growth factor receptor Nanobody with super(68)Ga via a novel bifunctional desferal chelate for immuno-PET
Published in European journal of nuclear medicine and molecular imaging (01-04-2011)“…Purpose: The 15 kDa variable domains of camelid heavy-chain-only antibodies (called Nanobodies registered ) have the flexibility to be formatted as monovalent,…”
Get full text
Journal Article